Click here for slides on this topic


Aspirin

Aspirin, or acetylsalicylic acid (acetosal), is a drug in the family of salicylates, often used as an analgesic (to releve minor aches and pains), antipyretic (to reduce fever), and anti-inflammatory (to reduce inflammation). It also has an antiplatelet ("blood-thinning") effect and is used in long-term, low doses to prevent heart attacks and thrombus formation in hypercoaguable statees (eg, in cancer).


The following content matched the glossary term: Aspirin

AHA ADA prevention of CVD in T2D - Aspirin Therapy

Top

Summary of recommendations for aspirin therapy from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

Managing the Patient With Type 2 Diabetes and Heart Failure

Top

.style1 FONT FAMILY Arial, Helvetica, sans serif COLOR #004685

ADA 2016 Older Adults

Top

Recommendations for older adults with diabetes from the 2016 ADA guidelines

ADA 2016 Cardiovascular Disease (CVD) and Diabetes

Top

Recommendations for CVD management, including lipids and BP, in patients with type 2 diabetes from the 2016 ADA diabetes guidelines

American Heart Association (AHA) Scientific Sessions 2012

Top

Exclusive coverage of late-breaking data from the American Heart Association Scientific Sessions, November 3-7, 2012 in Los Angeles, California are featured in this issue of OnsiteInsight®.

NDEI.org Expert Commentary Statins and Gender Peter Ganz

Top

Expert commentary on statins and gender from Peter Ganz, MD.

Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)

Top

McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Mangione CM, Herman WH. Diabetes Care. Predictors of mortality over 8 years in type 2 diabetic patients Translating Research Into Action for Diabetes (TRIAD). 2012 Mar 19. Epub ahead of print. To examine demographic, socioeconomic, and biological risk factors for all-cause, cardiovascular, and noncardiovascular mortality in patients with type 2 diabetes over 8 years and to construct mortality prediction equations.

Clinical Insights in Diabetes Newsletter Archive

Top

Clinical Insights® in Diabetes Newsletter Archive

Aspirin use and risk of type 2 diabetes in apparently healthy men

Top

Hayashino Y, Hennekens CH, Kurth T. Aspirin use and risk of type 2 diabetes in apparently healthy men. Am J Med. 2009;122(4):374-379. Epidemiologic data on aspirin use and the risk of diabetes are limited.

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

Top

Ogawa H, Nakayama M, Morimoto T, Uemura S, et al, for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300(18):2134-2141. Previous trials have investigated the effects of low-dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes.

1 2 Next 

Slide Library Results

Search Results for: Aspirin Slides Found: 17
Steno-2: Percentage of Patients at Treatment Goals at End of Study
ADVANCE: Study Design
POPADAD Trial: Causes of Death in Patients With Diabetes According to
POPADAD Trial: Effect of Antioxidant Use on Events in Patients With Diabetes
POPADAD Trial: Effect of Aspirin Use on Events in Patients With Diabetes
ADA/AHA/ACC: Recommendations for Use of Aspirin for Primary Prevention of CV Events in People With Diabetes
HPS2-THRIVE: Baseline Characteristics
CHAMPION PHOENIX: Randomization
ESH/ESC Hypertension Guidelines: Hypertension Treatment for Women
ESH/ESC Hypertension Guidelines: Treatment of Risk Factors Associated With Hypertension
ACC/AHA Cholesterol Guidelines 2013: Nonstatin Safety Recommendations: Niacin
IDF Type 2 Diabetes Guidelines CVD Risk Reduction Treatment | NDEI
IDF Type 2 Diabetes Guidelines Retinopathy Eye Screening | NDEI
Metformin Sulfonylureas Cancer Risk Type 2 Diabetes | NDEI
AACE 2015 Diabetes Guidelines Cardiovascular Disease Targets | NDEI
Aspirin Therapy Type 2 Diabetes CVD Prevention PPT | NDEI
Antiplatelet Therapy Recommendations ADA Guidelines | NDEI PPT